Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients

OBJECTIVES: The long-term goal for chronic hepatitis B patients is to maintain viral suppression in order to reduce disease progression risk. Because patients with previous treatment failure may have multiple viral resistance mutations, finding effective therapy is challenging. Because recent studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Baqai, Sumbella, Proudfoot, James, Xu, Ronghui, Kane, Steve, Clark, Margaret, Gish, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599168/
https://www.ncbi.nlm.nih.gov/pubmed/26462281
http://dx.doi.org/10.1136/bmjgast-2015-000030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599168/
https://www.ncbi.nlm.nih.gov/pubmed/26462281
http://dx.doi.org/10.1136/bmjgast-2015-000030

Ejemplares similares